Publicacions en què col·labora amb Jon Irazusta Astiazaran (12)

2018

  1. Obesity parameters, physical activity, and physical fitness are correlated with serum dipeptidyl peptidase IV activity in a healthy population

    Heliyon, Vol. 4, Núm. 5

2016

  1. Fibroblast activation protein predicts prognosis in clear cell renal cell carcinoma

    Human Pathology, Vol. 54, pp. 100-105

2015

  1. Aminopeptidase N activity predicts 5-year survival in colorectal cancer patients

    Journal of Investigative Medicine, Vol. 63, Núm. 5, pp. 740-746

  2. Plasma peptidases as prognostic biomarkers in patients with first-episode psychosis

    Psychiatry Research, Vol. 228, Núm. 2, pp. 197-202

2014

  1. Prolyl endopeptidase activity is correlated with colorectal cancer prognosis

    International Journal of Medical Sciences, Vol. 11, Núm. 2, pp. 199-208

2010

  1. Angiotensin-converting enzymes (ACE and ACE2) are downregulated in renal tumors

    Regulatory Peptides, Vol. 165, Núm. 2-3, pp. 218-223

  2. Expression and activity profiles of DPP IV/CD26 and NEP/CD10 glycoproteins in the human renal cancer are tumor-type dependent

    BMC Cancer, Vol. 10

  3. Increased prolyl endopeptidase activity in human neoplasia

    Regulatory Peptides, Vol. 163, Núm. 1-3, pp. 102-106

2009

  1. Increased APN/CD13 and acid aminopeptidase activities in head and neck squamous cell carcinoma

    Head and Neck, Vol. 31, Núm. 10, pp. 1335-1340

2007

  1. Altered levels of acid, basic, and neutral peptidase activity and expression in human clear cell renal cell carcinoma

    American Journal of Physiology - Renal Physiology, Vol. 292, Núm. 2

2003

  1. Effects of morphine administration and its withdrawal on rat brain aminopeptidase activities

    Regulatory Peptides, Vol. 110, Núm. 3, pp. 225-230

2002

  1. Distribution of prolyl endopeptidase activities in rat and human brain

    Neurochemistry International, Vol. 40, Núm. 4, pp. 337-345